[CLSTR]
< Back to situations

We’ll email you as it develops, and you can follow the whole thread from day one.

[SITUATION] · [ACTIVE]

2 clusters · 3 sources · 1 days · First seen · Last updated

Categories: BUSINESS

Institutional investors adjust US stock holdings

Entities: Amundi · AbbVie Inc. · Sutro Biopharma Inc. · Insulet Corporation · Norges Bank

Overview

On 1 August 2026, several institutional investors reported notable changes to their positions in U.S.-listed companies. French asset manager Amundi trimmed its stake in Gen Digital, selling 159,540 shares and reducing its holding to about 0.69% of the firm. At the same time, Amundi increased its position in Insulet Corporation, buying 56,225 shares to bring its ownership to roughly 0.65%.

Perceptive Advisors opened a new position in biotech firm Sutro Biopharma, acquiring 715,307 shares for an estimated $17.8 million, while Edgestream Partners more than doubled its Insulet holding, adding 12,277 shares for a 131 % increase. Additional investors such as Mitsubishi UFJ Trust & Banking, Aberdeen Group, OP Asset Management, Asset Management One, and Strs Ohio also adjusted their Insulet stakes.

These filings illustrate a broader pattern of asset managers rebalancing portfolios across technology, biotech, and medical‑device sectors, with both reductions and new purchases occurring within the same trading day.

Timeline

  1. 2 days ago

    [BUSINESS] 2 sources
    Insulet Corporation Gains New Institutional Shareholders

    Amundi and Edgestream Partners boosted their Insulet stakes in Q1, with Amundi now holding 0.65% of the company and Edgestream more than doubling its shares.

  2. 2 days ago

    [BUSINESS] 3 sources
    Institutional investors adjust holdings in Gen Digital and Sutro Biopharma

    Amundi cut its Gen Digital stake by 159,540 shares, while Perceptive Advisors bought 715,307 Sutro Biopharma shares, each adjusting holdings in the first quarter.

Sources

mommygearest.com · otravel.com · stocknews.com